In metabolic phenotypes (metabolic syndrome, obesity–diabetes overlap, autonomic neuropathy), neuro-metabolic imaging (31P-MRS, BOLD reactivity of hypothalamic networks) could select patients who express insulin-independent disposal shifts vs. those in whom the behavioral–executive route (DLPFC) dominates. This evidence concerns the gene INS and obesity disorder.